注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Globeimmune Inc是一家生物制药公司。该公司专注于开发基于其Tarmogen平台的治疗癌症和传染病的产品。该公司的Tarmogen平台通过刺激称为T细胞的白血球亚群来激活免疫系统,从而摧毁受感染或恶性细胞,这与主要刺激抗体产生的传统疫苗不同。Tarmogens还能减少调节性T细胞的数量和功能,从而进一步促成抗原特异性细胞免疫反应。该公司有两个以上的Tarmogen候选产品正在进行临床评估,用于传染病和多种癌症适应症。该公司的肿瘤学候选产品包括GI-6301, GI-6207和GI-4000。该公司的传染病候选产品包括GS-4774, GI-19000, GI-2010和GI-18000。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Richard C. Duke | - | 1996 | Scientific Founder & Member of Scientific Advisory Board |
Donald Bellgrau | - | 1996 | Scientific Founder & Chairman of The Scientific Advisory Board |
Bruce Walker | - | - | Member of Scientific Advisory Board |
Francis V. Chisari | - | 2005 | Member of Scientific Advisory Board |
Alan P. Venook | - | - | Member of Scientific Advisory Board |
Robert Peach | 66 | 2006 | Member of Scientific Advisory Board |
Edward Mocarski | - | 2004 | Member of Scientific Advisory Board |
Timothy C. Rodell | 71 | 2003 | Director |
Paul A. Bunn | 76 | - | Member of Scientific Advisory Board |
Carl H. June | 68 | - | Member of Scientific Advisory Board |
Charles A. Dinarello | 79 | - | Member of Scientific Advisory Board |
Jules Harris | - | 2006 | Member of Scientific Advisory Board |
Teresa Brentnall | - | 2004 | Member of Scientific Advisory Board |
Robert T. Schooley | - | - | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核